Christopher A. Schriever
Clinical Associate Professor, College of Medicine, Rockford
Clinical Associate Professor, Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
PHAR 506. Pathophysiology, Drug Action, and Therapeutics (PDAT) 6: Infectious Diseases (Phar 506), 1/9/2023 – 5/4/2023
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Selected Grants
ASHP Pharmacy Residency Expansion Grant Program - PGY1 2020, ASHP Research & Education Fdn., 7/1/2020 - 6/30/2021, Obligated Amount: $25000; Anticipated Amount: $25000
Reactions, attitudes, and perceptions of multidisciplinary teams during IPE outreach, Amer Assn of Colleges of Pharmacy., 9/1/2019 - 9/1/2020, Obligated Amount: $4000; Anticipated Amount: $4000
In Vitro Activity of Botanicals against Chlamydia pneumoniae isolates., National Institutes of Health., 12/2003 - Present, No Obligated Amount Set; No Anticipated Amount Set
In Vitro Activity of Botanicals against Chlamydia pneumoniae isolates., National Institutes of Health., 12/2003 - Present, No Obligated Amount Set; No Anticipated Amount Set
Metals in Exhaled Condensate as COPD Biomarker, National Institutes of Health., 10/1/2002 - 9/30/2006, No Obligated Amount Set; No Anticipated Amount Set
Metals in Exhaled Condensate as COPD Biomarker, National Institutes of Health., 10/1/2002 - 9/30/2006, No Obligated Amount Set; No Anticipated Amount Set
Development of Monoclonal Antibodies to Viral Peptides of the Mushroom Infecting La France Virus, Campbell Soup Corporation., 7/1993 - Present, No Obligated Amount Set; No Anticipated Amount Set
Immunosurveillance of Active TB by Breath Condensate, Society of Infectious Disaeses Pharmacists., Date Not Set - Present, No Obligated Amount Set; No Anticipated Amount Set
Production and Efficacy of F(ab)2 Fragments on Cell Proliferation on Burkitt’s Lymphoma Cell Line Jijoye, Department of Hematology and Oncology at the University of Iowa., Date Not Set - Present, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Schriever, Christopher, Hays, Annette. (2023). Antimicrobial Agents. Rau’s Respiratory Care Pharmacology. Elsevier.
Schriever, Christopher, Hays, Annette. (2022). Pharmacology. First Aid Cases for the USMLE Step 1, Third Edition. McGraw Hill Professional.
Schriever, Christopher A, Danziger, Larry H. (2020). Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?. Clinical Infectious Diseases, 71, (1), 87-88. doi:10.1093/cid/ciz814.
Ziegler, Jason, Chapman, Heather, Rueth, Megan, Hays, Annette, Schriever, Christopher, Tsaras, Geoffrey. (2020). Potential Perinatally Acquired Extended Spectrum β-Lactamase Escherichia coli Urinary Tract Infection in an Infant. The Journal of Pediatric Pharmacology and Therapeutics, 25, (3), 266-269. doi:10.5863/1551-6776-25.3.266.
Biagi, MJ, Schriever, CA, Chiampas, TD, Michienzi, SM, Patel, MC, Young, JD, Badowski, ME. (2020). Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide. International Journal of STD & AIDS, 31, (4), 380-382. doi:10.1177/0956462419895665.
Michienzi, Sarah M, Cai, Jiaqi, Harris, Cydnee, Kim, Sean, Patel, Nimish, Badowski, Melissa E, Chan, Juliana, Martin, Michelle T, Schriever, Christopher A. (2019). 356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment. Open Forum Infectious Diseases, 6, (Supplement_2), s187-s187. doi:10.1093/ofid/ofz360.429.
Ahmed, Alisha, Schriever, Christopher, Britt, Nicholas, Yager, Jenna, Amin, Ronish, McGuey, Liam, Patel, Nimish. (2019). Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Annals of Hepatology, 18, (4), 601-606. doi:10.1016/j.aohep.2019.01.005.
Michienzi, Sarah M, Schriever, Christopher A, Badowski, Melissa E. (2019). Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis. International Journal of STD & AIDS, 30, (2), 181-187. doi:10.1177/0956462418800865.
Hemenway, Alice N, Christensen, Alyssa, Schriever, Christopher. (2018). Treatment considerations for potential uropathogens detected by precision microbiological testing. American Journal of Health-System Pharmacy, 75, (22), 1775-1782. doi:10.2146/ajhp180208.
Professional Leadership
ASHP Section Advisory Group (SAG), American Society of Health-System Pharmacists, 8/22/2022 - 12/7/2023
Spring Planning Committee, Illinois Counsel of Health-System Pharmacist, 9/1/2020 - 3/1/2021
Drug Utilization Review Board, State of Illinois, 9/5/2017 - Present
Immunization Advisory Committee, State of Illinois, 11/19/2013 - Present
Research Committee, 8/1/2011 - 8/1/2021
Education
Degrees:
Doctor of Pharmacy, University of Illinois at Chicago, United States, 1999
Master of Science, Northern Illinois University, United States, 1993
Bachelor of Science, University of Iowa, United States, 1987
Associate of Science, Rock Valley College, United States, 1985
Postgraduate Training:
Infectious Diseases Fellowship, University of Illinois at Chicago, United States, 2002
Pharmacy Practice Residency (PGY-1), VA Chicago Health System West Side and Lakeside, United States, 2000
Licensures and Certifications
Expert / Pharmacist, American Academy of HIV Medicine, 2010 - Present
National Certificate for Pharmacist, American Pharmacists Association, 11/2010 - Present
APHA Certified Immunization Trainer, American Pharmacists Association, 2012 - Present
Registered Pharmacist, State of Illinois, 9/1999 - Present